Carson Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Carson Advisory's PFE Position: Q1 2026 in Review
Carson Advisory reduced its Pfizer (PFE) stake by 1.5% in Q1 2026, selling an estimated $3.62K and leaving 9,174 shares worth $258K. The position accounts for 0.13% of the portfolio, ranked #156.
Carson Advisory first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.4M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Carson Advisory held 9,174 shares of Pfizer worth $258K as of Q1 2026.
- Carson Advisory sold 136 Pfizer shares in Q1 2026, an estimated $3.62K.
- Pfizer made up 0.13% of Carson Advisory's portfolio in Q1 2026, its #156 holding.
- Carson Advisory first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Carson Advisory's Pfizer position peaked at $1.4M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.